XML 27 R18.htm IDEA: XBRL DOCUMENT v3.20.2
Medical Oncology Partners (Tables)
 9 Months Ended
Sep. 30, 2020
Medical Oncology Partners LLC [Member]  
Schedule of Equity Method Investments [Line Items]  
Equity Method Investment Summarized Financial Information
The following table presents the summarized financial information of MOP:

MOP Condensed Consolidated Income Statement Information

  
Nine Months Ended
September 30,
(Unaudited)
 
  
2020
  
2019
 
       
Patient revenue
 
$
1,473,000
  
$
2,015,000
 
         
Net loss
 
$
(1,041,000
)
 
$
(205,000
)
         
USNC's equity in loss in MOP
 
$
(373,000
)
 
$
(73,000
)

  
Three Months Ended
September 30,
(Unaudited)
 
  
2020
  
2019
 
       
Patient revenue
 
$
541,000
  
$
668,000
 
         
Net loss
 
$
(345,000
)
 
$
(102,000
)
         
USNC's equity in loss in MOP
 
$
(124,000
)
 
$
(36,000
)

MOP Condensed Consolidated Balance Sheet Information

  
September 30,
2020
  
December 31,
2019
 
  
(Unaudited)
    
       
       
Current assets
 
$
180,000
  
$
247,000
 
         
Noncurrent assets
  
575,000
   
807,000
 
         
Total assets
 
$
755,000
  
$
1,054,000
 
         
Current liabilities
 
$
2,671,000
  
$
1,907,000
 
         
Noncurrent liabilities
  
305,000
   
427,000
 
         
Deficit
  
(2,221,000
)
  
(1,280,000
)
         
Total liabilities and deficit
 
$
755,000
  
$
1,054,000